Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,568 total articles
MaxLinear has moved from obscurity to a data-center connectivity play as hyperscalers spend on optical and networking subsystems for AI servers. The company is small enough to re-rate quickly but carries valuation and execution risk. This is a long swing trade: entry $94.48, stop $78.00, target $150.00 over a mid-term horizon (45 trading days).
AMD’s GPU momentum has captured investor headlines, but the more durable profit re-rating could come from continued CPU share gains and margin recovery. I’m initiating a long trade on AMD with a clear entry, stop, and target tied to a 180 trading day horizon — betting that the market will broaden its valuation beyond the GPU story and reward sustai…
Booking Holdings owns some of the most efficient distribution assets in travel (Booking.com, Priceline, Agoda, KAYAK, OpenTable). The business converts sales into free cash flow at scale ($9.03B FCF) and today trades below prior highs, offering a favorable risk-reward. This trade targets a rebound over the next 180 trading days with a clear stop to…
Obsidian Energy (OBE) looks primed to convert higher commodity selling prices and recent asset monetization into visible upside. The company’s sale of Cardium assets for roughly $301M materially changes the balance sheet picture versus a market cap of ~$545M, and technical oversold signals set up a tradeable rebound. We outline a long trade with a …
Old Dominion (ODFL) has been punishing shareholders through a slow freight cycle, but recent results and operating strength argue for a tactical long. The business still converts cash, carries almost no debt, and has room to re-rate if volumes stop falling and pricing holds. This trade idea lays out an entry, stop, target and the catalysts and risk…
NIO's May delivery surge and better vehicle margins have put fundamental footing under a beaten-down share price. With technicals oversold and short interest still meaningful, there's a defined, asymmetric trade: buy a measured dip and target the $5.80 area while limiting downside. This is a mid-term trade (45 trading days) that balances momentum a…
MTY Food Group offers a pragmatic mid-term trade: buy a stable, franchised restaurant portfolio trading at a modest multiple, use an entry at $18.50 with a $27.00 target over ~45 trading days while protecting downside with a $15.00 stop. The thesis blends yield-like cash generation and capital return optionality with a near-term technical/opportuni…
USA Rare Earth (USAR) is positioning itself as a domestic mine-to-magnet supplier after securing material federal and private funding and acquiring downstream capacity. The stock combines strategic optionality with early-stage operational risk: market cap ~ $4.7B, enterprise value ~$3.15B, negative EPS and free cash flow, but $3.5B in recent fundin…
Tennant Company (TNC) reported a painful ERP-driven hit to sales and earnings in 2025, but the business still generates positive cash flow, sits on a modest balance sheet and trades at reasonable enterprise multiples. This trade idea targets a recovery as execution and customer service normalize, while keeping a tight stop to limit exposure to lega…
DAI and similar multi-collateral stablecoins typically trade close to their $1 peg. Short-lived deviations create tradeable mean-reversion opportunities. This note outlines a practical, risk-managed long trade on DAI around a small sub-$1 drift: entry $0.995, target $1.005, stop $0.985, horizon 10 trading days.
SSR Mining's announced $1.5B sale of its 80% Copler stake, a newly authorized 10% buyback and a strong free cash flow profile shift the company's risk/return profile. With net cash-like balance sheet metrics, attractive FCF yield and multiple catalysts ahead, this is a buy for a position-horizon trade.
Newmark (NMRK) trades at a reasonable multiple with improving technicals and a recent strategic bolt-on that should help valuation reset. Enter a mid-term long ahead of Q2 results with a clear stop and measured upside targets—this is a tactical, risk-aware trade that banks on an earnings catalyst and continued recovery in transaction volumes.
Global-e (GLBE) is a cross-border e-commerce enabler that just agreed to acquire Passport for $350M plus up to $75M in earnouts. The deal brings meaningful near-term revenue ($~100M expected in 2026) and logistics capabilities that can lift margins and reduce merchant churn. With a market cap of ~$5.82B, improving fundamentals and bullish technical…
The Hanover Insurance Group (THG) offers durable underwriting returns, a tidy dividend and low leverage. At $207.56 the stock sits near its 52-week high with a P/E near 10 and free cash flow of $1.25B — attractive on the surface. That said, near-term upside appears capped unless pricing momentum or investment income accelerates. I recommend a Hold:…
Alumis built a valuation around envudeucitinib after two positive Phase 3 psoriasis readouts. The next 3-6 months — pivotal lupus data in Q3 and an expected NDA in Q4 2026 — will tell whether those results translate into a commercial opportunity. This trade idea lays out a long entry with clear stop and target, plus the risks that could unravel the…
Nano Labs (NA) is a sub-$50m market cap fabless chip and AI-infrastructure holding company trading near its 52-week low. The stock looks cheap on headline multiples (P/E ~1.85, P/B ~0.38) and has a handful of tangible catalysts (product launches, a North America MOU, insider buying). This is a high-risk, event-driven long: enter at the current pric…
Marvell has gone from near-obscurity to center stage in the AI infrastructure boom. With a $246B market cap, high growth guidance, a strategic $2B Nvidia tie-up, and accelerating optical and ASIC demand, the business story is intact. Technicals show a short-term pullback — presenting a mid-term trading opportunity with defined entry, stop, and targ…
Spotify reported a clear long-term plan at its Investor Day and set aggressive North Star targets - 1 billion subscribers, $100B revenue, and >40% gross margin by 2030. The market punished near-term misses earlier this year, creating an entry near recent support. Given a still-healthy subscriber TAM, margin levers in ad and podcast monetization, an…
Crinetics (CRNX) combines an FDA-approved oral acromegaly drug showing durable control with an advancing late-stage ACTH antagonist program. Recent ENDO 2026 data and early commercial revenue give a tangible growth runway. This trade idea targets a mid-term momentum move while keeping an eye on clinical and commercial execution risks.
RTX combines commercial aerospace (Pratt & Whitney, Collins) with high-margin defense businesses (Raytheon Intelligence & Space, Raytheon Missiles & Defense). At $186.59 the stock offers durable free cash flow ($8.46B), a modest dividend, and a balance-sheet that finances growth and buybacks. We outline an actionable long trade with entry, stop and…
FitLife Brands (FTLF) shows early signs the Irwin Naturals acquisition is accretive: EPS of $0.64, a reasonable P/E near 18.6, EV/EBITDA ~12.4, and bullish technical momentum. We outline a mid-term long trade with clear entry, stop and target alongside catalysts and risks.
VSE's Aviation business is getting a growth jolt from recent Precision Aviation Group integration and MRO demand. The stock is trading with momentum and constructive technicals, but valuation is rich and headline risk is real. This trade proposes a mid-term swing long with a strict stop and clear targets.
Salesforce has been punished with a deep multiple reset even as revenue growth remains healthy and free cash flow is strong. At roughly $150 a share the stock offers a low-teens P/E, robust FCF generation and tangible AI and M&A catalysts. This trade idea lays out an entry at $150.215, a disciplined stop and a $210 target over a 180-trading-day hor…
Solventum (SOLV) looks like a compelling swing trade after a modest pullback. The stock trades at an attractive P/E (~9-9.3) relative to growth, carries a buyback tailwind and solid ROE, but the balance sheet and negative free cash flow add real risk. Entry around $76, stop at $73.75, target $88 over a mid-term 45 trading day horizon.
<p>Boston Scientific (BSX) has tumbled from a $109.50 52-week high to trade near $44.27 today, punished by guidance cuts and procedure mix headwinds. Fundamentals still show scale, cash generation and manageable leverage, while recent positive trial data and a strategic push into TAVR create asymmetric upside. This is a tactical, mid-term trade loo…
